Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...

Full description

Saved in:
Bibliographic Details
Main Authors: Zdeněk Kejík, Robert Kaplánek, Petr Dytrych, Michal Masařík, Kateřina Veselá, Nikita Abramenko, David Hoskovec, Martina Vašáková, Jarmila Králová, Pavel Martásek, Milan Jakubek
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
CTCs
NSCLCs
metastasis suppression
curcumin
flavonoids
Pharmacy and materia medica
RS1-441
Online Access:https://doaj.org/article/a9212fe2fd9443cd854b6088bd96b44c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/a9212fe2fd9443cd854b6088bd96b44c

Similar Items